PMA device
Clareon Aspheric Hydrophobic Acrylic Intraocular Lens with the AutonoMe Pre- Loaded Delivery System
Alcon Laboratories, LLC · Intraocular Lens (HQL, Class III) · First FDA decision Jan 7, 2020, newest Aug 17, 2026Cataract
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
6
PMA pathway
Device trials
6
Naming "Clareon Aspheric Hydrophobic"
MAUDE reports
940
Brand "Clareon Aspheric Hydrophobic", since 2015
PubMed studies
0
Mentioning "Clareon Aspheric Hydrophobic"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Clareon Aspheric Hydrophobic Acrylic Intraocular Lens with the AutonoMe Pre- Loaded Delivery System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 6 of 6 decisions filed under this name.
- Clareon Aspheric Hydrophobic Acrylic Intraocular Lens with the AutonoMe Pre- Loaded Delivery System, Clareon Toric AsphePMA supplement
P190018-S051 · Decided Aug 17, 2026 · 88 days after receipt · Normal 180 Day Track
Device type: intraocular lens (HQL) · Ophthalmology
- Clareon Aspheric Hydrophobic Acrylic IOL (SY60WF); Clareon Aspheric UV Absorbing IOL (CC60WF); Clareon Toric Aspheric UVPMA supplement
P190018-S048 · Decided Apr 30, 2026 · 90 days after receipt · Normal 180 Day Track
Device type: intraocular lens (HQL) · Ophthalmology
- Clareon Aspheric Hydrophobic Acrylic Intraocular LensesPMA supplement
P190018-S039 · Decided Jun 18, 2025 · 190 days after receipt · Normal 180 Day Track No User Fee
Device type: intraocular lens (HQL) · Ophthalmology
3 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Intraocular Lenses (IOLs)National determinationOn the books80.12Updated Aug 17, 2023
- Intraocular PhotographyNational determinationOn the books80.6Updated Apr 17, 2020
- Ophthalmic Biometry for Intraocular Lens Power CalculationLocal determinationIn effectL33621Wellpoint FederalUpdated Jul 14, 2026
- Ophthalmic Biometry for Intraocular Lens Power CalculationLocal determinationIn effectL34181CGS Administrators, LLCUpdated May 29, 2026
- Anterior segment intraocular nonbiodegradable drug-eluting systemProposed local determinationProposedDL40385WPS Insurance CorporationUpdated May 14, 2026
- Anterior segment intraocular nonbiodegradable drug-eluting systemProposed local determinationProposedDL40356CGS Administrators, LLCUpdated May 14, 2026
- Anterior segment intraocular nonbiodegradable drug-eluting systemProposed local determinationProposedDL40367Palmetto GBAUpdated May 14, 2026
- Anterior segment intraocular nonbiodegradable drug-eluting systemProposed local determinationProposedDL40363National Government Services, Inc.Updated May 14, 2026
Clinical trials
Device studies on ClinicalTrials.gov that name "Clareon Aspheric Hydrophobic", any status and sponsor, newest update first.
- Clareon Toric Study (T2-T9)Completed
Alcon ResearchNot on our public-company list
NCT06285695 · 129 participants · Start Apr 10, 2024 · Primary completion Jun 25, 2026
Device: Clareon Toric IOL · For: Aphakia; Corneal Astigmatism
Sites: Calgary, Canada; Concord, Canada; Oakville, Canada · 6 sites in all
Alcon ResearchNot on our public-company list
NCT05852470 · 155 participants · Start May 23, 2023 · Primary completion Oct 27, 2023
Device: Clareon Vivity/Vivity Toric Extended Vision IOL; Clareon Monofocal/Clareon Toric IOL · For: Aphakia
Sites: Torrance, California; Fort Collins, Colorado; Bloomfield Hills, Michigan · 7 sites in all
- Clareon Toric vs Eyhance ToricPivotal-lookingCompleted
Alcon ResearchNot on our public-company list
NCT05481125 · 203 participants · Start Oct 10, 2022 · Primary completion Oct 16, 2023
Device: Clareon IOL; Clareon Toric IOL and 2 more · For: Cataract; Aphakia
Sites: Poughkeepsie, New York; Brecksville, Ohio; Mt. Pleasant, South Carolina · 8 sites in all
3 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Clareon Aspheric Hydrophobic", and for the whole product code for context.
This brand
940 reports: 840 malfunction, 100 injury, 0 death
Whole product code HQL
40,785 reports: 26,247 malfunction, 14,467 injury, 2 death
Newest reports for this brand
- Clareon Aspheric Hydrophobic Acrylic IOLMalfunction
Alcon Research, LLC - Huntington
1119421-2026-02144 · Received Oct 27, 2026 · Event dated Oct 1, 2026
Device type: Intraocular Lens (HQL)
Device problem as coded: Material Split, Cut or Torn
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- Clareon Aspheric Hydrophobic Acrylic IOLMalfunction
Alcon Research, LLC - Huntington
1119421-2026-02143 · Received Oct 27, 2026 · Event dated Sep 19, 2026
Device type: Intraocular Lens (HQL)
Device problem as coded: Product Quality Problem
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- Clareon Aspheric Hydrophobic Acrylic IOLMalfunction
Alcon Research, LLC - Huntington
1119421-2026-02145 · Received Oct 27, 2026 · Event dated Sep 28, 2026
Device type: Intraocular Lens (HQL)
Device problem as coded: Failure to Deliver
Patient problem as coded: Insufficient Information
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Alcon Laboratories Ireland, Ltd
Z-1269-2022 · Started May 11, 2022
Reason given: Due to device (preloaded intraocular lens) mislabeling, associated with partial mixing of product during overlapping manufacturing runs, and attributed to improper manufacturing line clearance.
Cause as FDA categorized it: Under Investigation by firm · Device type: Intraocular Lens (HQL)
Published research
The most relevant PubMed records for "Clareon Aspheric Hydrophobic"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code HQL.
- SENSAR Soft Acrylic Posterior Chamber IOLJohnson & Johnson Surgical Vision, Inc. · PMA 2025
- TECNIS Toric 1-Piece Intraocular Lense (IOLs)Johnson & Johnson Surgical Vision, Inc. · PMA 2020
- TECNIS Symfony Toric Extended Range of Vision IOLsJohnson & Johnson Surgical Vision, Inc. · PMA 2021
- Akreos Posterior Chamber Intraocular LensBausch & Lomb, Inc. · PMA 2021
- Acrysof Iq Toric IOL with the Ultrasert Pre Loaded Delivery System ModelsAlcon Laboratories, Inc. · PMA 2017
- Softec Hd Posterior Chamber Intraocular Lens (Pciol)Lenstec, Inc. · PMA 2014
- Posterior Chamber Intraocular LensesAaren Scientific · PMA 2001
- TECNIS Foldable Acrylic IOL with OptiEdgeJohnson & Johnson Surgical Vision, Inc. · PMA 2025
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.